Pan-Cancer Analysis of the Prognostic and Immunological Role of HSF1: A Potential Target for Survival and Immunotherapy

Figure 3

Association between the HSF1 expression and the OS of cancer patients. (a) A forest plot of hazard ratios of HSF1 in 33 types of tumors. (b) Kaplan-Meier survival curves of OS for patients stratified by the different expressions of HSF1 in LAML, LUAD, LIHC, KIRP, and THCA.

(a)

(b)